Investment Committee Summary
| Rating | SELL |
| Internal 5-tier | SELL |
| Classification · conviction | balance-sheet repair · low |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | ~$35 (≈ -16% vs spot) — precision reflects LOW valuation confidence |
| 12-mo scenario PWEV | ~$36 (≈ -12% vs spot) |
| Next catalyst | 2026-09-16 — Quarterly earnings |
| Primary thesis-break | Organic net sales growth (y/y) < 0.0 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: SELL
Internal 5-tier: SELL · balance-sheet repair · analyst conviction: low
| Metric | Value |
|---|---|
| Current Price | $40.92 |
| Triangulated Fair Value | $34.57 (-16% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $35.86 (-12% vs spot · 12m PWEV) |
| Forward P/E | 12.6x |
| Market Cap | $22B |
| 52-Week Range | $31.64–$51.27 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across two weighted anchors — a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 48.4/100 (14th pct) | -12% 1yr expected | Hold | Put Debit Spread | 22d — Quarterly earnings |
Research rating: SELL · Tactical / decision-rule stance: Hold — the stance is the machine decision-rules layer (hysteresis, kill-switches, freshness); the rating is the valuation verdict. They may diverge and are reconciled in the Decision Rules section below.
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: SELL
Defensive: rating SELL; triangulated fair value $34.57 (-16% vs spot) — the risk/reward is skewed to the downside on Gross Margin. The debate is Gross Margin — a fundamental call.
Investment Thesis
At $40.92 (25 August 2026) General Mills is capitalised on about 13x forward earnings and a high-single-digit dividend yield — a rating that already prices packaged food as a structurally declining, GLP-1- and private-label-impaired franchise with little terminal value. The engine does not argue for a re-rating. Its twelve-month base-case target is $35.86, the probability-weighted value is $35.86, and the blend lands at $34.57, -16% against spot, leaving the shares trading rich to intrinsic value at a SELL rating. Read the tree rather than the headline: the base path, in which price and mix offset flat volume on a 12% operating margin, carries only about a third of the weight, and the structural path carries nearly a quarter. The disagreement with the market is narrow in level but wide in method — the cash-flow anchor sits far below the simulated median, a divergence the engine itself flags, and that gap shows how much of the value rests on the terminal multiple rather than on near-term cash. The single most damaging risk is that GLP-1 adoption and private-label trade-down prove structural, collapsing volume and multiple at once, with net debt of ~$13.2B leaving little room to defend the payout.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($40.92) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear is the structural path, and it is credible rather than a token hedge. Appetite suppression from GLP-1 therapies durably shrinks centre-store consumption in exactly the cereal, snack and baking categories that anchor the portfolio, while stretched households trade down permanently to private label, which now offers comparable quality at a persistent price gap. Volume falls and cannot be repriced away; lost fixed-cost absorption de-levers an already-thin 12% operating margin further; and the market re-rates the equity as a melting ice cube toward a low-single-digit multiple. With net debt of ~$13.2B and a payout consuming most of free cash flow, there is no buffer, so a dividend cut becomes plausible — and the yield that attracts the marginal holder today is the first thing to go. The structural target sits below the 52-week low.
Key Debate
Gross Margin explains 60% of Monte Carlo outcome variance — the single variable that decides which side is right.
What the Market Is Pricing In
At the current price, the market pays 13.3× consensus forward EPS, vs the house DCF terminal 9.0×, and a peer median 16.6×. The house DCF sits 76% below spot, so the market is pricing in more than the house case — roughly 2.5pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 17.8 | 18.7 | High |
| EPS | 3.1 | 3.3 | Medium |
| Target price | 37.6 | 35.9 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($15.40) to a 'Bull — Margin Recovery / Re-Rate' bull case ($62.20); the probability-weighted blend (PWEV $35.86) is -12% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — GLP-1 / Private-Label Erosion | 24% | $15.40 | -62% |
| Volume / Cost Recession | 18% | $29.30 | -28% |
| Base — Price/Mix Offsets Volume | 32% | $39.80 | -3% |
| Growth — Snacking + Premiumization | 18% | $51.00 | +25% |
| Bull — Margin Recovery / Re-Rate | 8% | $62.20 | +52% |
| Probability-Weighted (PWEV) | — | $35.86 | -12% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.4% of revenue; free cash flow net of SBC is $1.55B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — GLP-1 / Private-Label Erosion (24%, $15.40). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Volume / Cost Recession (18%, $29.30). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising.
- Base — Price/Mix Offsets Volume (32%, $39.80). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns.
- Growth — Snacking + Premiumization (18%, $51.00). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Margin Recovery / Re-Rate (8%, $62.20). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery.
Valuation Triangulation
Two weighted anchors — a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat two numbers as two independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $32.42 | -21% | 37% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $48.78 | +19% | 0% — cross-check only |
| Scenario PWEV | multiple | $35.86 | -12% | 62% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $10.03 | -75% | 0% — excluded |
| Triangulated (weighted) | — | $34.57 | -16% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name DCF, sum-of-parts, peer P/E re-rate are not computed, so 60% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $32.42 and 33% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (60% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.0%, 9.0x terminal FCF multiple → $10.03. Excluded from the weighted blend as an outlier — retained as an independent cross-check on the multiple-driven anchors.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $48.78; the peer-median forward P/E is 16.6x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 108% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 6.3x | 7.6x | 9.0x | 10.3x | 11.7x |
|---|---|---|---|---|---|
| 6.0% | $5.83 | $9.21 | $12.86 | $16.25 | $19.89 |
| 7.0% | $4.69 | $7.93 | $11.41 | $14.64 | $18.12 |
| 8.0% | $3.62 | $6.70 | $10.03 | $13.11 | $16.43 |
| 9.0% | $2.60 | $5.55 | $8.72 | $11.66 | $14.84 |
| 10.0% | $1.63 | $4.44 | $7.47 | $10.29 | $13.32 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-1.86 | $1.98 | $5.81 | $9.65 | $13.48 |
| -1.5pp | $-0.30 | $3.78 | $7.86 | $11.94 | $16.03 |
| +0.0pp | $1.34 | $5.69 | $10.03 | $14.37 | $18.71 |
| +1.5pp | $3.08 | $7.69 | $12.31 | $16.93 | $21.54 |
| +3.0pp | $4.90 | $9.81 | $14.72 | $19.62 | $24.53 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $1.00 | $19.00 | $17.00 |
| Revenue CAGR ±3pp | $6.00 | $15.00 | $9.00 |
| Terminal × ±15% | $7.00 | $13.00 | $6.00 |
| Capex intensity ±15% | $8.00 | $12.00 | $4.00 |
| WACC ±1pp | $9.00 | $11.00 | $3.00 |
Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 11.0x)
| Multiple | 7.7x | 9.3x | 11.0x | 12.6x | 14.3x |
|---|---|---|---|---|---|
| SoP/share | $8.00 | $15.00 | $22.00 | $29.00 | $36.00 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| MDLZ | 20.2× | 2% | 9% | broad | 25% |
| HSY | 21.3× | 2% | 21% | broad | 25% |
| KHC | 11.2× | 2% | 21% | direct | 100% |
| TSN | 12.9× | 2% | 4% | direct | 100% |
Quality-weighted forward P/E: 13.8× (simple median 16.6×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (exit) (excluded (>3× or <0.3× spot)). Anchor median 32.7. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $31.64–$51.27, centre $40.30 (-2% vs spot); spot sits at the 47th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $34.57 (-16% vs spot · triangulated FV) |
| Downside to bear case (Structural — GLP-1 / Private-Label Erosion) | $15.40 (-62% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -18% |
| P(price > spot) — Monte Carlo | 33% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Margin Recovery / Re-Rate): $62.20.
Company Overview & Business Model
General Mills Inc — CONSUMER DEFENSIVE · PACKAGED FOODS. General Mills, Inc., is an American multinational manufacturer and marketer of branded consumer foods sold through retail stores. It is headquartered in Golden Valley, Minnesota, a suburb of Minneapolis.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Packaged Foods | 100% | +2% | 12% | packaged-food volume + price/mix vs private-label + GLP-1 + input costs |
Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Packaged Foods | $18.4B | 100% | 2% | 12% | $2.3B | 11.0x | 4% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | packaged-food volume + price/mix vs private-label + GLP-1 + input costs |
| net_debt_or_cash_b | -13.18 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.0698 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | GLP-1 / private-label erosion |
| upside | snacking + premiumization + margin recovery |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $13.1B — highly levered |
| Net debt / EBITDA | 3.79x |
| Interest coverage (EBIT / interest) | 4.9x |
| Current ratio | 0.68x |
| Lease obligations | $0.4B |
| Cash & ST investments | $0.5B |
Balance-sheet data as of 2026-05-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.6B |
| Buybacks / dividends | $0.5B / $1.3B |
| Total shareholder yield | 8.3% |
| Payout as % of FCF | 111.6% |
| Reinvestment (capex / OCF) | 24.9% |
| SBC as % of FCF | 4.9% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 8.8% |
| FCF conversion (FCF / net income) | -1912.9% |
| FCF yield | 7.4% |
| Capex intensity (capex / revenue) | 2.9% |
| FCF − SBC (diagnostic) | $1.6B |
| Capex split (maint / growth) | 75% / 25% — Mature packaged-food asset base: spend is mostly maintenance of plants and automation, with limited capacity growth in a low-volume-growth category. |
Accounting quality: SBC 1% of revenue.
Competitive Moat
Moat sources:
- Portfolio of leading center-store and pet brands (Cheerios, Blue Buffalo, Pillsbury)
- Retail distribution scale and shelf-space relationships with grocers
- Advertising/scale economics in a mature category
- Offset: private-label substitution and GLP-1 appetite suppression eroding volume and pricing power
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q3): management +0.43 vs analyst floor +0.22 → delta +0.21 (n=20 mgmt / 16 Q&A; 13th pctile across the S&P book, z -1.2).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q3 | +0.43 | +0.22 | +0.21 |
| 2026Q2 | +0.29 | +0.19 | +0.10 |
| 2026Q1 | +0.26 | +0.00 | +0.26 |
| 2025Q4 | +0.47 | +0.26 | +0.21 |
News (last 365d, 1428 articles): avg ticker sentiment +0.04 (bullish 10% / bearish 9%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $37.56 (-8% vs spot · street) |
| House target | $35.86 (-4.5% vs street) |
| Sell-side coverage | 20 analysts (SB 3 / B 1 / H 12 / S 2 / SS 2; net score 0.03) |
| Consensus FY EPS | $3.08 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $17.8B; house above (+5.1%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-09-16 (~23d) — Quarterly earnings — est. EPS $0.73 (AV EARNINGS_CALENDAR)
- 2026-09-23 (~30d) — Pet (Blue Buffalo) segment re-acceleration checkpoint (authored)
- 2027-02-28 (~188d) — Portfolio reshaping / M&A or divestiture decision (authored)
Forecast Track Record
- EPS surprise: beat 88% of the last 8 quarters; average surprise +4.9%.
- Prior-forecast backtest (12 snapshots, 2026-06-26→2026-08-20): directional hit-rate 25%; mean predicted -1.8% vs realised +12.0%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 22d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-09-23 (in 29d) | Pet (Blue Buffalo) segment re-acceleration checkpoint | authored | ● | 0.7 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-02-28 (in 187d) | Portfolio reshaping / M&A or divestiture decision | authored | ● | 0.7 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Front-of-pack labeling / added-sugar and marketing-to-children rules | medium (~40%) | low - reformulation cost and volume drag; <5% of FV | 12-24m |
| Ingredient/food-dye and SNAP-eligibility policy shifts | low (~25%) | low - marginal to mix; <5% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — GLP-1 / Private-Label Erosion | GLP-1 adoption structurally lowers packaged-food volume while private label takes share in a value-conscious consumer environment. | Volume decline outruns price/mix, threatening margin and dividend coverage as the multiple stays depressed. |
| Volume / Cost Recession | A weak consumer trades down and input-cost inflation re-accelerates faster than pricing can pass through. | Margin compression with no volume offset squeezes FCF and the payout. |
| Base — Price/Mix Offsets Volume | Modest volume declines are offset by price/mix and productivity, holding EPS roughly flat. | Elasticity turns and further price increases accelerate the volume loss they are meant to offset. |
| Growth — Snacking + Premiumization | Snacking and premium/pet mix shift restores low-single-digit organic growth and modest margin recovery. | GLP-1 headwind caps the snacking tailwind the case relies on. |
| Bull — Margin Recovery / Re-Rate | Cost deflation plus successful premiumization drives margin recovery and a re-rate toward the staples cohort. | A structurally declining category rarely earns a durable re-rate; any volume miss reverses it. |
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 1 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-12.37 | YES |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-12.37 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.03 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
no data | — |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.05 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.74 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic net sales growth (y/y) < 0.0 (2 consecutive prints). Two consecutive quarters of negative organic growth would confirm that price/mix can no longer offset volume erosion, validating the volume/cost-recession mechanism over the mid-cycle base.
- Retail pound/unit volume (y/y) < -0.03 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Adjusted operating margin < 0.107 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Private-label unit share in core categories > 0.02 (2 consecutive prints). Accelerating private-label share gains of more than 2pp would evidence permanent brand-equity erosion, supporting the multiple-compression leg of the structural scenario.
- FY revenue vs guidance < 18.5 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $40.92; 52-week range $31.64–$51.27; engine rating SELL; house target $35.86 (-12%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $34.57 (-16% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
48.4/100 (confidence band 34.3–62.6), 14th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 28 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 20 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 38 | 15% | upside_pct |
| growth | 44 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 88 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 50 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 91 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 45 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 46.0 → 46.0 → 46.7 → 46.0 → 46.0 → 48.8 → 48.8 → 48.8.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — GLP-1 / Private-Label Erosion | 24% | $15.40 | -62.4% | -15.0pp |
| Volume / Cost Recession | 18% | $29.30 | -28.4% | -5.1pp |
| Base — Price/Mix Offsets Volume | 32% | $39.80 | -2.7% | -0.9pp |
| Growth — Snacking + Premiumization | 18% | $51.00 | +24.6% | +4.4pp |
| Bull — Margin Recovery / Re-Rate | 8% | $62.20 | +52.0% | +4.2pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | -12.4% |
| Expected return net of SBC dilution | -12.4% |
| Outcome dispersion (σ, from MC p10–p90) | 43.0% |
| Expected Sharpe (rf 4%) | -0.38 |
| Downside expectation (prob-weighted loss branches) | -21.0% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | -12.4% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 0.16 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 4.7% |
| Expected alpha | -17.1% |
| Alpha per unit risk (EA/σ) | -0.40 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 35.4% (1σ) | 23.7% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 26.0% | 32.8% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $35.86.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 1 | AI | 1 | |
| Value | 62 | Cloud | 25 | |
| Quality | 11 | Semis | 2 | |
| Momentum | 22 | Consumer | 19 | |
| Low-Vol | 33 | Rates | 53 | |
| USD | 61 | |||
| Energy | 79 |
Market interaction: correlation vs SPY -0.03, vs QQQ -0.18 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Put Debit Spread. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- bearish with cheap options — buy defined-risk downside
- Direction bearish from the overlay conviction/rating (read-only input).
- IV/RV at the 20th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 75th percentile of its own month-end history (decile 8). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +3.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +3.9pp): 25-DTE 30% · 116-DTE 32% · 389-DTE 34%
| Priced structure | Value |
|---|---|
| Legs | Long 40 P, Short 35 P |
| Expiry | 2027-03-19 |
| Max loss | $1.88 |
| Max profit | $3.12 |
| Net debit | $1.88 |
| Return on risk | 167.0% |
| Breakeven | $38.12 |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: Protective Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
research rating is SELL-tier — the model carries no long position.
| Parameter | Value |
|---|---|
| Initial position | 0.00% NAV |
| Maximum position | 0.00% NAV |
| Risk budget | 0.00% NAV |
| Annualized outcome σ (MC) | 43.0% |
| Indicative holding period | 6–18 months |
| Liquidity | high, ~$311M ADV (adv usd 21 (split-adjusted 21d average, AM-046)) |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the SELL equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 29.8% (subdued regime) · expected move ±6.2% (2026-09-18) · put/call OI 0.99 · ATM Δ 0.65 / Θ -0.03 / ν 0.04 · next earnings 2026-09-16. Direction: SHORT/HEDGE (implied return -15.5% to triangulated fair value $34.57).
Bear Put Spread (Bearish) — Long 40 P / Short 35 P · 2027-03-19 · net debit $1.88 · max profit $3.12 · breakeven $38.12 · RoR 167.0% · max loss $1.88 · priced from the listed chain (EOD marks)
Defined-risk downside expression: the debit caps the loss, with the position gaining as the stock falls toward the lower strike — a way to act on a bearish view without shorting stock. Subdued implied volatility currently lowers the premium paid. Illustrative — no outcome is implied or guaranteed.
Protective Put (if held) (Hedge) — Long 40 P · 2027-03-19 · premium $3.3 · floor -2.0% · max loss $3.30 · priced from the listed chain (EOD marks)
Insurance for an existing holding — a known premium buys a floor while leaving the upside intact. A way to hold through a binary event or volatility with defined downside.
Protective Collar (if held) (Hedge) — Long 37.5 P / Short 45 C · 2027-03-19 · net $0.05 · floor -8.0% · cap +10.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = SELL because:
- Probability-weighted scenario value implies -12% vs spot
- Monte Carlo median implies -21% vs spot
- DCF fair value implies -75% vs spot — but this is terminal-value sensitive (exit-multiple $10.03 vs Gordon $32.89, 228% apart), so it carries less weight
- Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -62% vs spot
- Net: the valuation anchor itself sits 15.5% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $19B | $2B | $1B | $1B | $2B | $2B |
| FY+2 | $19B | $2B | $1B | $1B | $2B | $1B |
| FY+3 | $19B | $2B | $1B | $1B | $2B | $1B |
| FY+4 | $20B | $2B | $1B | $1B | $2B | $1B |
| FY+5 | $20B | $3B | $1B | $1B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 9.0x | $11B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.0% · Σ PV(FCF) $7B + PV(terminal) $11B = EV $19B; − net debt $13.2B → equity $5B ÷ diluted shares $0.54B = $10.03/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $32.89/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 8% vs WACC 8.0% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| MDLZ | 2.5x | 20.2x | 2% | 9% |
| HSY | 3.4x | 21.3x | 2% | 21% |
| KHC | 1.8x | 11.2x | 2% | 21% |
| TSN | 0.5x | 12.9x | 2% | 4% |
| Median | 2.1x | 16.6x | — | — |
Implied prices at the peer medians: EV/Rev → $48.78 (no P/E-implied price — no forward-EPS basis at the peer step).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| Scenario PWEV | $35.86 | 62% | $22.41 |
| Monte Carlo median | $32.42 | 37% | $12.16 |
| Triangulated | — | 100% | $34.57 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 8.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 9× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (17.0); Revenue CAGR ±3pp (9.0); Terminal × ±15% (6.0); Capex intensity ±15% (4.0); WACC ±1pp (3.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $18.4B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $18.7B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $3.0781 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.537B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $13.084B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 8.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 9× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 8.0%, terminal multiple 9×, FY+5 revenue $20B. Triangulation leans 62% on PWEV, 37% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.